---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-046730"
form_type: "8-K"
ticker: "GALT"
cik: "0001133416"
company_name: "GALECTIN THERAPEUTICS INC"
filed_at: "2024-11-14T23:59:59+00:00"
generated_at: "2026-05-30T00:15:58.496138+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Galectin Therapeutics posts updated corporate presentation; exhibit truncated, specific content unknown

## Summary
- Filed updated corporate presentation on Nov 14, 2024, for use at investor conferences and meetings.
- Presentation available on company website; includes forward-looking statements.
- Exhibit 99.1 appended but truncated in filing text; no new financial or pipeline details visible.
- No specific guidance, trial results, or financing changes disclosed in the filing body.

## SEC filing metadata
- accession: 0001140361-24-046730
- form_type: 8-K
- ticker: GALT
- cik: 0001133416
- company_name: GALECTIN THERAPEUTICS INC
- filed_at: 2024-11-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133416/000114036124046730/0001140361-24-046730-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133416/000114036124046730/ef20038323_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-046730
- JSON: https://secwatch.observer/filing/0001140361-24-046730.json
- Plain text: https://secwatch.observer/filing/0001140361-24-046730.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.